AVOST PLUS
TRAVOPROST USP + TIMOLOL MALEATE BP
| NAME | STRENGTH | PACK SIZE | DOSAGE FORM |
|---|---|---|---|
| AVOST PLUS 0.004% W/V + 0.5% W/V | 0.004% W/V + 0.5% W/V | 3 ML | EYE DROP |
Avost Plus Eye Drops : Each ml contains Travoprost USP 0.04 mg and Timolol Maleate BP equivalent to Timolol 5 mg.
Travoprost is a prostaglandin analogue which reduces IOP by increasing trabecular outflow & uveoscleral outflow. Timolol is a non-selective beta adrenergic receptor blocker that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anesthetic (membrane stabilizing) activity. It lowers IOP by decreasing the formation of aqueous humor in the ciliary epithelium.
Avost Plus is indicated for the treatment of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension who are insufficiently responsive to single therapy with prostaglandin analogue or topical beta blocker.
Instill one drop in the conjunctival sac of the affected eye(s) once daily at about the same time each day, preferably in the evening.
Contraindicated in patients who are hypersensitive to Travoprost, Timolol or any of the components of this preparation.
For ophthalmic use only. Patients should remove their contact lenses prior to instilling this preparation and should not insert their lenses until 15 minutes after instillation of the preparation.
The most frequently reported treatment-related side-effect was ocular hyperemia. Approximately 3% of patients discontinued treatment due to conjunctival hyperemia.
Pregnancy: There are no adequate and well-controlled studies in pregnant women. It should not be used during pregnancy. Lactation: Caution should be exercised when it is administered to a nursing mother.
Studies have not been conducted.
No information available.
Store at 2° – 25° C. No refrigeration required.
Avost Plus Eye Drops : Each plastic dropper bottle contains 3 ml sterile eye drops